CurrentCardio
Get Weekly

Topic · page 12 of 21

Prevention & lipids

Lipids, Lp(a), lifestyle (activity, diet, alcohol, smoking), risk scores, primary prevention in general or older populations, frailty and CV risk

Briefs 441–480 of 838 placed here, newest publication first

Briefs in Prevention & lipids

Newest publication first

  1. J Am Coll Cardiol

    Characterization of Arterial Aneurysms in Loeys-Dietz Syndrome

    Cohort study

  2. Eur J Prev Cardiol

    Proposal of a familial hypercholesterolemia paediatric diagnostic score (FH-PeDS)

    Cross-sectional study

  3. Circulation

    A Systematic Review of “Food Is Medicine” Randomized Controlled Trials for Noncommunicable Disease in the United States: A Scientific Statement From the American Heart Association

    Guideline or statement

  4. Eur J Prev Cardiol

    Sitting–rising test scores predict natural and cardiovascular causes of deaths in middle-aged and older men and women

    Cohort study

  5. J Am Coll Cardiol

    10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population

    Cross-sectional study

  6. Eur J Prev Cardiol

    Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factors

    Meta-analysis

  7. Eur J Prev Cardiol

    Association between high occupational physical workload and ischaemic heart disease, and the influence of cardiorespiratory fitness in 284 436 Swedish men

    Cohort study

  8. Eur J Prev Cardiol

    Diet and nutrition in cardiovascular disease prevention: a scientific statement of the European Association of Preventive Cardiology and the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology

    Guideline or statement

  9. Eur J Prev Cardiol

    Improvements in walking speed reduce mortality in patients with cardiovascular disease during exercise-based secondary prevention: findings from the ITER registry

    Cohort study

  10. Eur J Prev Cardiol

    Remnant cholesterol lowering in cardiovascular disease risk reduction in statin, ezetimibe, and PCSK9 inhibitor trials: meta-regression analyses

    Randomised controlled trial

  11. Circulation

    Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association

    Guideline or statement

  12. JACC Cardiovasc Imaging

    Mid- to Late-Life Traditional Cardiovascular Risk Factor Exposure and Zero Coronary Artery Calcium: The ARIC (Atherosclerosis Risk in Communities) Study

    Cohort study

  13. Eur J Prev Cardiol

    Evaluating the role of lipoprotein(a) in enhancing risk stratification for the presence and extent of subclinical coronary artery disease burden: a BioHEART-CT study

    Cross-sectional study

  14. J Am Coll Cardiol

    Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies

    Cross-sectional study

  15. J Am Coll Cardiol

    Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy

    Secondary analysis

  16. JAMA Cardiol

    Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors

    Cross-sectional study

  17. Eur J Prev Cardiol

    External validation of the 2023 American Heart Association Predicting Risk of cardiovascular disease EVENTs equations for atherosclerotic cardiovascular disease in primary cardiovascular prevention setting and comparison with 2021 Systematic COronary Risk Evaluation and 2013 Pooled Cohort Equations

    Diagnostic or prognostic study

  18. Eur J Prev Cardiol

    External validation of cardiovascular risk scores in patients with Type 2 diabetes using the Spanish population-based CARDIANA cohort

    Diagnostic or prognostic study

  19. BMJ

    A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial

    Randomised controlled trial

  20. Eur J Prev Cardiol

    Childhood exposure to multiple types of violence and adult cardiovascular disease

    Cohort study

  21. Circulation

    Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial

    Randomised controlled trial

  22. Eur J Prev Cardiol

    Risk factors associated with gastrointestinal bleeding in patients with cardiovascular disease (INTERBLEED): a case control study

    Case-control study

  23. Eur J Prev Cardiol

    Development and validation of the CARE-DM model to predict the cardiovascular risk in older persons with type 2 diabetes

    Diagnostic or prognostic study

  24. Eur J Prev Cardiol

    Associations of visit-to-visit lipid variability with coronary artery calcification and cardiovascular event in statin-naïve Koreans

    Cross-sectional study

  25. N Engl J Med

    Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk

    Randomised controlled trial

  26. Lancet

    Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial

    Randomised controlled trial

  27. Eur Heart J

    Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement

    Guideline or statement

  28. Eur Heart J

    Lipoprotein(a) and recurrent atherosclerotic cardiovascular events: the US Family Heart Database

    Cohort study

  29. Eur J Prev Cardiol

    Cascade screening in familial hypercholesterolaemia is associated with earlier statin initiation and fewer cardiovascular events than opportunistic screening

    Cohort study

  30. J Am Coll Cardiol

    Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD: The VICTORION-Mono Randomized Clinical Trial

    Randomised controlled trial

  31. Eur Heart J

    Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events

    Cohort study

  32. JAMA Cardiol

    Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation: Two Cluster Randomized Clinical Trials

    Randomised controlled trial

  33. JAMA Cardiol

    Food Insecurity and Incident Cardiovascular Disease Among Black and White US Individuals, 2000-2020

    Cohort study

  34. Eur J Prev Cardiol

    Cardiovascular outcomes in adults with low-density lipoprotein cholesterol levels of ≥4.9 mmol/L: 15-year follow-up of the CoLaus|PsyCoLaus study

    Cohort study

  35. Circulation

    Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study

    Case-control study

  36. Eur J Prev Cardiol

    Underestimation of cardiovascular risk by the SCORE2 model in primary care: a call for recalibration

    Cohort study

  37. Eur J Prev Cardiol

    Review of strategies to improve adherence to lipid-lowering therapy in the primary prevention of cardiovascular disease

    Research article

  38. J Am Coll Cardiol

    Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults

    Cross-sectional study

  39. JAMA

    Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease: A Randomized Clinical Trial

    Randomised controlled trial

  40. J Am Coll Cardiol

    Prepregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife

    Secondary analysis

All 838 Briefs in ExploreShowing Briefs 441–480 of 838, newest first